EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Alterations in serum levels of the natural anticoagulants in chronic liver disease and their relations to portal thrombosis

Orhan SEZGİN ¹ , Perihan OĞUZ ² , Selime AYAZ ³

Author Affiliation(s)

1.

Department of Internal Medicine, Division of Gastroenterology, Mersin University School of Medicine, Mersin

2.

Türkiye yüksek İhtisas Hastanesi Gastroenteroloji Kliniği, Ankara

3.

Departments of Hematology, Türkiye Yüksek İhtisas Hospital, Ankara

Turk J Gastroenterol 1998; 9: 313-316

Keywords : antithrombin III, liver cirrohosis, chronic active hepatitis, portal vein thrombosis.

Read: 2105 Downloads: 1844 Published: 25 July 2019

Volume 9, Issue 4, December 1998

Previous Article

Files